Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Alzheimer Disease - Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
Anxiety Disorders - Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
Celsion Corporation - Celsion Provides Update on Its Global Pivotal Phase III Primary Liver Cancer Trial
Endoscopy - Study Published in Gastrointestinal Endoscopy Features Computer-Assisted Personalized Sedation (CAPS)
Obesity and Diabetes - First Reported Head-to-Head Study Showed BYETTA® (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia (sitagliptin) in Patients With Type 2 Diabet
Pneumococcal Disease - Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
Breast Cancer Clinical Trial - Reports outline breast cancer clinical trial research from University of Oklahoma, Health Science Center
Intravenous Immunoglobulin - Studies from King Saud University, Department of Pediatrics further understanding of intravenous immunoglobulin
Life Sciences - Research from I.C. Munro and co-researchers provides new data on life sciences
Anthera Pharmaceuticals - Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
Anthrax Vaccines - PharmAthene Awarded NIAID Contract for Up to $83.9 Million for Third Generation rPA Anthrax Vaccine Program
Applied Data Research - Wirelessly Enabled Cardio Implants Serving as Flagship Application for Remote Patient Monitoring
Aurora Imaging Technology Inc. - Breast Care Specialists of Atlanta First in U.S. to Offer Patients Two Aurora Dedicated Breast MRI Systems at a Single Location
AVANIR Pharmaceuticals - AVANIR Presents Data at American Neurological Association Annual Meeting
BellTower Technologies LLC - BellTower Technologies Launches FoodAlert.org, Nation's First FREE High-Speed Telephone Food Recall and Safety Notification Service for American Consumers and Their Families
Bioengineering - Southern Research Institute Launches Consulting Company to Advance Scientific Innovation Through Biosafety and Health Risk Management
Biogen Idec - Biogen Idec Features Data on AVONEX and TYSABRI and Showcases the Company's Multiple Sclerosis Development Pipeline at the World Congress On Treatment and Research in Multiple Sclerosis
Bracco Diagnostics Inc. - Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into Agreement to Co-Promote Bracco's CardioGen-82 Rubidium Rb 82 Generator
Breast Cancer - Study Shows Radiation Device May Customize Therapy, Enable Some to Avoid More Lengthy Treatment
Bristol-Myers Squibb - ERBITUX Five-Year Data Show Significant Improvement in Overall Survival for Patients with Locally or Regionally Advanced Head and Neck Cancer
Cancer - F.D.A. Approves SANCUSO®, the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
Cancer Vaccines - Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer; Collaboration Will Target New Tools to Enhance Early Cancer Detection and Intervention
Cardiology - Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
Cellumen, Inc. - Cellumen Selected as Signature Partner of Drug Safety Executive Council
Cornerstone Pharmaceuticals Inc. - Cornerstone Pharmaceuticals Announces Initiation of Clinical Trials of CPI-613 for the Treatment of Cancer
Covidien - Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
Diabetes - Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Diabetes - MicroCHIPS Names Tamborlane to New Scientific Advisory Board
DizzyFIX - Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA
DNA Research - Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
Drinking Water Research Foundation - Drinking Water Research Foundation Chairman Calls Environmental Protection Agency Ruling Unacceptable Risk for Americans
Drug Resistance - AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)
Dyax Corp. - Dyax Announces Completion of Biologics License Application for DX-88 for Hereditary Angioedema
EraGen Biosciences Inc. - EraGen Receives Health Canada Approval of Five MultiCode-RTx Molecular Diagnostic Tests
GE Healthcare - FDA Approves GE Healthcare's AdreView Iobenguane I 123 Injection Diagnostic Agent for Detecting Neuroendocrine Tumors in Children, Adults
Genzyme Corporation - Genzyme Provides Details of October Myozyme alglucosidase alfa Advisory Panel Meeting and Additional Regulatory Updates
Guided Therapeutics, Inc. - Guided Therapeutics, Inc. Announces Completion of Subject Enrollment of FDA Pivotal Clinical Trial
Heart Failure - 2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting
Heart Failure - Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
Heart Failure - FDA Accepts New Drug Application for Bucindolol, a Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Heart Failure - Naturoceuticals: Are They Good or Bad for Patients with Heart Failure?
Heart Failure - Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
HIV/AIDS - Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
HIV/AIDS - Landmark Campaign Reaches Rural Kenyans with Tools to Prevent Malaria, Diarrhoeal Disease and HIV
HIV/AIDS - Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
Hormones - Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Hormones - Biopartners presents three year safety and efficacy data for sustained release recombinant human growth hormone (LB03002) at ESPE 2008
Hypophosphatasia - Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
I-Flow Corporation - I-Flow Corporation Receives 510k Clearance From FDA for Oxygenated Topical Dressing
IDEV Technologies Inc. - IDEV Technologies Inc. and YMED Inc. Announce 510k Clearance for Larger and Longer Sizes of the VascuTRAK2 PTA Dilation Catheter for the Treatment of Peripheral Artery Disease
Immunization - Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations
ImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Elects Dr. James Bender to Position of Vice President, Clinical Development
Inspire Pharmaceuticals, Inc. - Inspire Initiates Special Protocol Assessment Process for Prolacria Trial for Dry Eye
Invasive Pest Coalition - Invasive Pest Coalition Calls on Governor to Sign Huffman/Laird Bills ASAP
Life Sciences - Bridgehead International US Expansion continues
NovaDel Pharma Inc. - NovaDel Pharma Announces PDUFA Deadline Extension on Zolpimist
OBS Medical - OBS Medical Receives New FDA 510k Clearance Expanding Visensia Solutions for Hospital Patient Safety
Orthovita, Inc. - Orthovita Announces New VITOSS Bioactive Foam Pack Bone Graft Substitute
Osiris Therapeutics, Inc. - Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
Osteosarcoma - IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
Pediatrics - AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
Pediatrics - Novel Drug Development Alliance Between Napo Pharmaceuticals and Direct Relief International Targets Global Implications of Pediatric Diarrhea
PPD, Inc. - PPD Confirms Takeda's NDA Submission of Alogliptin and ACTOS to U.S. Food and Drug Administration
Pressure BioSciences, Inc. - Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the
Sinupret for Kids - Back to Nature: Clinically Tested Natural Remedy Sinupret for Kids Introduced in the US
Surgery - Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
Talecris Biotherapeutics - Sub-Analysis of Phase III Study Suggests More than Single Treatment may be Required for Therapeutic Response in Some Patients with CIDP
Talecris Biotherapeutics - Sub-Analysis of Phase III Suggests Long-Term Therapy May Improve Physical and Social Functioning In CIDP Patients
Tris Pharma, Inc. - Tris Pharma Completes Its Facilities' Expansion, Receives FDA Clearance
Type 2 Diabetes - Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
